THE State-owned National Pharmaceutical Company (NatPharm) distributed drugs worth US$240 million in 2024 to public health institutions across the country as it bids to improve availability of medical supplies. This comes as the curative services chief director in the ministry of Health, Maxwell Hove, told the parliamentary portfolio committee on Health last year that MPs…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions